Management of polymyalgia rheumatica in older people

Polymyalgia rheumatica ( PMR ) is the most common inflammatory rheumatic disease affecting older people. For decades it has remained under‐researched and poorly understood, despite causing significant disability. Once thought to be a self‐limiting condition universally responsive to a limited course of prednisolone, it is now clear that most people with PMR require prolonged corticosteroids beyond two years. The cumulative burden of adverse...